Underdog Launches With $4M to Target “Toxic” Form of Cholesterol
Underdog Pharmaceuticals has launched with nearly $4 million in seed funding to develop treatments for atherosclerosis, a progressive condition in
Category: Uncategorized
International Conference on Nanomedicine and Nanotechnology
International Conference on Nanomedicine and Nanotechnology is going to be held in Dublin, Ireland on May 20-21, 2020, focusing on the theme “Empowering success
World Congress on Neuroscience and Brain Disorders
“World Congress on Neuroscience and Brain Disorders” is scheduled to be held from March 30-31, 2020 in Osaka, Japan. The
Cyclo Therapeutics Announces Completion of Enrollment in its Phase I Trial to Evaluate Trappsol® Cyclo™ for the Treatment of Niemann-Pick Disease Type C
Cyclo Therapeutics, Inc. formerly CTD Holdings, Inc., a biotechnology company that develops cyclodextrin-based products for the treatment of disease, announced
Oculis started Phase II clinical trial with OCS-01 in Treating Inflammation and Pain in Post-cataract Patients
Oculis S.A., a clinical-stage biopharmaceutical company whose mission is to develop novel topical treatments (eye drops) for ophthalmic diseases, announced
Cyclodextrins in doll-inspired nanostructures for cancer therapy
A young researcher working at the Centre de Recherche en Automatique de Nancy, Centre National de la Recherche Scientifique has recently
Amgen’s Kyprolis, J&J’s Darzalex team up on myeloma survival win
After years of slow growth, Amgen’s Kyprolis finally looks poised to break the blockbuster barrier in 2019, and new data
New real-world data support long-term efficacy and safety profile of MAVENCLAD
Merck, a leading science and technology company, announced the presentation of new data for MAVENCLAD® (cladribine tablets), which further characterise
Cyclodextrin-based nanozymes
Nanozymes are nanomaterials with enzyme-like properties. These artificial enzymes have emerged more robust than the natural enzymes and find applications
Pharma-Congress – 2019
The conference on “Pharmaceutical Drug Research and Industry Field Innovations” is scheduled to be held on November 25-26, 2019 Singapore. The theme